SCHEMBL7302427

SCHEMBL7302427

CC[C@H](C)[C@H](NC(=O)N(C)Cc1ccccn1)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.60
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
POLB P06746 1/20 0.44
PTPRA P18433 1/20 0.41
KEAP1 Q14145 1/20 0.41
NFE2L2 Q16236 1/20 0.41
ADAMTS4 O75173 1/20 0.41
KCNK3 O14649 1/20 0.41
FPR2 P25090 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
ATM Q13315 1/20 0.40
MAPK1 P28482 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 1/20 0.39
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7393135 1.00 CA2 (0.60) CA2CYP2C9CYP2C19POLBPTPRA
SCHEMBL27395775 1.00 CA2 (0.60) CA2CYP2C9CYP2C19POLBPTPRA
SCHEMBL4683895 0.90 CA2 (0.67) CA2POLBPTPRAKEAP1NFE2L2
SCHEMBL4683897 0.90 CA2 (0.67) CA2POLBPTPRAKEAP1NFE2L2
SCHEMBL4683611 0.88 CA2 (0.55) CA2POLBALDH1A1MAPT
SCHEMBL7305636 0.88 CA2 (0.48) CA2CYP2C9CYP2C19POLBMEN1
SCHEMBL4683608 0.88 CA2 (0.55) CA2POLBALDH1A1MAPT
SCHEMBL27373122 0.84 CA2 (0.54) CA2POLBPTPRAKCNK3KMT2A
SCHEMBL7299441 0.84 CA2 (0.54) CA2POLBPTPRAKCNK3KMT2A
SCHEMBL7340523 0.83 CA2 (0.85) CA2CYP2C19CYP1A2CYP2D6MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575097-B1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS LILLY CO ELI (US) 2000-11-02 EP disclosed
US-5578608-A HIV PROTEASE INHIBITOR ELI LILLY AND COMPANY (US) 1996-11-26 US disclosed
EP-0575097-A1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS ELI LILLY AND COMPANY (US) 1993-12-22 EP disclosed